期刊
NATURE CELL BIOLOGY
卷 9, 期 4, 页码 453-U171出版社
NATURE PUBLISHING GROUP
DOI: 10.1038/ncb1563
关键词
-
类别
资金
- Medical Research Council [MC_U142684175, MC_U142684172, MC_U142661184] Funding Source: Medline
- Wellcome Trust Funding Source: Medline
- Medical Research Council [MC_U142684175, MC_U142661184, MC_U142684172] Funding Source: researchfish
- MRC [MC_U142684172, MC_U142684175, MC_U142661184] Funding Source: UKRI
Pancreatic islets have a central role in blood glucose homeostasis. In addition to insulin-producing beta-cells and glucagon-secreting alpha-cells, the islets contain somatostatin-releasing delta-cells(1). Somatostatin is a powerful inhibitor of insulin and glucagon secretion(2). It is normally secreted in response to glucose(3) and there is evidence suggesting its release becomes perturbed in diabetes(4). Little is known about the control of somatostatin release. Closure of ATP-regulated K+-channels (K-ATP-channels)(5) and a depolarization-evoked increase in cytoplasmic free Ca2+ concentration ([Ca2+](i))(6-8) have been proposed to be essential. Here, we report that somatostatin release evoked by high glucose (>= 10 mM) is unaffected by the K-ATP-channel activator diazoxide and proceeds normally in K-ATP-channel-deficient islets. Glucose-induced somatostatin secretion is instead primarily dependent on Ca2+-induced Ca2+-release (CICR). This constitutes a novel mechanism for K-ATP-channel-independent metabolic control of pancreatic hormone secretion.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据